Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

The virosomal adjuvanted influenza vaccine.

Calcagnile S, Zuccotti GV.

Expert Opin Biol Ther. 2010 Feb;10(2):191-200. doi: 10.1517/14712590903431014. Review.

PMID:
20088714
2.

MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk.

Durando P, Icardi G, Ansaldi F.

Expert Opin Biol Ther. 2010 Apr;10(4):639-51. doi: 10.1517/14712591003724662. Review.

PMID:
20218923
3.

Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine.

Herzog C, Hartmann K, Künzi V, Kürsteiner O, Mischler R, Lazar H, Glück R.

Vaccine. 2009 Jul 16;27(33):4381-7. doi: 10.1016/j.vaccine.2009.05.029. Epub 2009 May 29. Review.

PMID:
19450630
4.

Influenza vaccination in the elderly.

Glück R, Wegmann A.

Dev Comp Immunol. 1997 Nov-Dec;21(6):501-7. Review.

PMID:
9463783
5.

The virosome concept for influenza vaccines.

Huckriede A, Bungener L, Stegmann T, Daemen T, Medema J, Palache AM, Wilschut J.

Vaccine. 2005 Jul 8;23 Suppl 1:S26-38. Review.

PMID:
16026906
6.
7.

MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations.

Puig Barberà J, González Vidal D.

Expert Rev Vaccines. 2007 Oct;6(5):659-65. Review.

PMID:
17931147
8.

Influenza control in the 21st century: Optimizing protection of older adults.

Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, Puig-Barberà J, Schmitt J, Stephenson I.

Vaccine. 2009 Aug 13;27(37):5043-53. doi: 10.1016/j.vaccine.2009.06.032. Epub 2009 Jun 24. Review.

PMID:
19559118
9.

Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

Durando P, Iudici R, Alicino C, Alberti M, de Florentis D, Ansaldi F, Icardi G.

Hum Vaccin. 2011 Jan-Feb;7 Suppl:29-40. Epub 2011 Jan 1. Review.

PMID:
21245655
10.

Influenza vaccines: the virosome concept.

Wilschut J.

Immunol Lett. 2009 Feb 21;122(2):118-21. doi: 10.1016/j.imlet.2008.11.006. Epub 2008 Dec 25. Review.

PMID:
19100779
11.

Recombinant vaccines for influenza virus.

Tripp RA, Tompkins SM.

Curr Opin Investig Drugs. 2008 Aug;9(8):836-45. Review.

PMID:
18666031
12.

Humoral immune response to influenza vaccination in patients from high risk groups.

Brydak LB, Machala M.

Drugs. 2000 Jul;60(1):35-53. Review.

PMID:
10929929
13.

Inactivated influenza vaccines: recent progress and implications for the elderly.

Parodi V, de Florentiis D, Martini M, Ansaldi F.

Drugs Aging. 2011 Feb 1;28(2):93-106. doi: 10.2165/11586770-000000000-00000. Review.

PMID:
21275435
14.
15.

Safety, immunogenicity and efficacy of influenza vaccine in children.

Cintra OA, Rey LC.

J Pediatr (Rio J). 2006 Jul;82(3 Suppl):S83-90. Epub 2006 Jun 21. Review.

16.

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control.

Kreijtz JH, Osterhaus AD, Rimmelzwaan GF.

Hum Vaccin. 2009 Mar;5(3):126-35. Epub 2009 Mar 15. Review.

PMID:
18948744
17.

Utility of virosomal adjuvated influenza vaccines: a review of the literature.

Gasparini R, Lai P.

J Prev Med Hyg. 2010 Mar;51(1):1-6. Review.

PMID:
20853669
18.

Is there a role for a mucosal influenza vaccine in the elderly?

Corrigan EM, Clancy RL.

Drugs Aging. 1999 Sep;15(3):169-81. Review.

PMID:
10503810

Supplemental Content

Support Center